Endometriosis News

A new study in BMC Medicine explores how blood-based metabolite and lipoprotein profiling could help distinguish endometriosis from other conditions, potentially opening the door to less invasive diagnostic tools.

Yale researchers analyzed more than 1.4 million genomes to identify 80 genomic regions linked to endometriosis risk, nearly doubling the known genetic landscape. The findings, published in Nature Genetics, point to new drug repurposing opportunities and highlight genetic overlaps with adenomyosis.

Endometriosis affects roughly one in ten women of reproductive age in the United States, yet diagnosis is often delayed for years. Yale experts explain why the disease is so hard to identify and why it is increasingly understood as a whole-body condition.

Two landmark reviews published in The Lancet Obstetrics, Gynaecology & Women’s Health reveal that nearly half of all WHO member states lack national policies or clinical guidance for endometriosis care, spotlighting deep global inequities.

Campaigners in the UK are calling for a national endometriosis registry, saying it could lead to faster diagnosis, better treatment, and improved outcomes. Nearly 3,500 people have signed a petition supporting the effort.

The first daily pill for treating endometriosis symptoms has been approved for use on the NHS in England and Wales, offering a new option for patients who have tried other treatments.